Physician

Akil Hassam, MD

According to 2025 Medicare claims, Akil Hassam, MD (NPI: 1700198975) practices gastroenterology in the Johnstown, PA market, with the plurality of this provider's patient population coming from Cambria, PA. This provider's primary affiliated billing organization is DLP CONEMAUGH PHYSICIAN PRACTICES LLC (NPI: 1205242609; TIN: 320442710) and primary practice location at 15905-4305. Hassam is affiliated with the AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Hassam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 230 traditional Medicare patients, billed 338 HCPCS/CPT codes, and received $36,451 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,439 prescription claims across 630 beneficiaries totaling $3,911,289 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 19 records totaling $603. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $19,552 to $3,911,289. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$25K$50K2019 Medicare payment: $50,320 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $42,555 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $47,697 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $39,792 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $38,695 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $36,451 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019261552$50,320
2020241436$42,555
2021256442$47,697
2022242363$39,792
2023251349$38,695
2024230338$36,451

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0M$3.9M2016 Drug cost: $19,552 (USD; Tot_Drug_Cst)2017 Drug cost: $113,771 (USD; Tot_Drug_Cst)2018 Drug cost: $6,021 (USD; Tot_Drug_Cst)2019 Drug cost: $41,916 (USD; Tot_Drug_Cst)2020 Drug cost: $42,128 (USD; Tot_Drug_Cst)2021 Drug cost: $250,981 (USD; Tot_Drug_Cst)2022 Drug cost: $1,293,937 (USD; Tot_Drug_Cst)2023 Drug cost: $3,109,232 (USD; Tot_Drug_Cst)2024 Drug cost: $3,911,289 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161642$19,552
201737122$113,771
20181927$6,021
201978197$41,916
2020132329$42,128
2021226754$250,981
20224581,627$1,293,937
20235952,175$3,109,232
20246302,439$3,911,289

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare5961$180
45380Biopsy of large bowel using a flexible endoscope3434$94
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4455$88
43235Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope2933$72
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope3739$53

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
StelaraUstekinumab643,108$1,772,137
Humira(Cf) PenAdalimumab842,352$636,471
Skyrizi On-BodyRisankizumab-Rzaa14784$291,491
RinvoqUpadacitinib26758$222,081
EntyvioVedolizumab191,064$161,015

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.19$603Phathom Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Akil Hassam, MD?

Tedicare shows public-source Medicare data for Akil Hassam, MD (NPI 1700198975), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akil Hassam, MD have ACO affiliation data?

Akil Hassam, MD is shown with ACO affiliation data for AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Akil Hassam, MD?

Akil Hassam, MD is linked to DLP CONEMAUGH PHYSICIAN PRACTICES LLC (billing NPI 1205242609) in the available physician profile data.

Does Akil Hassam, MD have Open Payments data?

Akil Hassam, MD has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.